Transgene (XPAR:TNG) Other Operating Expense : €-3.55 Mil (TTM As of Dec. 2023)

View and export this data going back to 1998. Start your Free Trial

What is Transgene Other Operating Expense?

Transgene's Other Operating Expense for the six months ended in Dec. 2023 was €-1.12 Mil. Its Other Operating Expense for the trailing twelve months (TTM) ended in Dec. 2023 was €-3.55 Mil.

Transgene's quarterly Other Operating Expense declined from Dec. 2022 (€-1.31 Mil) to Jun. 2023 (€-2.43 Mil) but then increased from Jun. 2023 (€-2.43 Mil) to Dec. 2023 (€-1.12 Mil).

Transgene's annual Other Operating Expense declined from Dec. 2021 (€-1.74 Mil) to Dec. 2022 (€-2.53 Mil) and declined from Dec. 2022 (€-2.53 Mil) to Dec. 2023 (€-3.55 Mil).

Transgene Other Operating Expense Historical Data

The historical data trend for Transgene's Other Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Transgene Other Operating Expense Chart

Transgene Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Other Operating Expense

Get a 7-Day Free Trial

-3.14

-2.35

-1.74

-2.53

-3.55

Transgene Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Other Operating Expense	Get a 7-Day Free Trial															-0.06	-1.22	-1.31	-2.43	-1.12

Transgene Other Operating Expense Calculation

GuruFocus uses a standardized financial statement format for all companies. For non-financial companies, GuruFocus lists Selling, General, & Admin. Expense, , Research & Development, and Other Operating Expense under the "Total Operating Expense" section.

Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)

Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.

Other Operating Expense for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was €-3.55 Mil.

Transgene Other Operating Expense Related Terms

Thank you for viewing the detailed overview of Transgene's Other Operating Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Transgene (XPAR:TNG) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Transgene SA (XPAR:TNG) » Definitions » Other Operating Expense

Comparable Companies

Traded in Other Exchanges

TGNA:Germany

Address

400 Boulevard Gonthier d’Andernach, Parc d’Innovation - CS80166, Illkirch-Graffenstaden, FRA, 67400

Website

https://www.transgene.fr

Transgene SA is a biotechnology company. It is involved in the business of discovering and focusing immune-targeted therapies for the treatment of cancer and infectious diseases. The company's clinical-stage programs are TG4010 for non-small cell lung cancer and Pexa-vec for liver cancer. Its product pipeline includes TG4001, TG1050, TG6002 etc. It is engaged in clinical research and development of therapeutic vaccines and immunotherapeutic products.

Transgene (XPAR:TNG) Headlines

No Headlines